Precisely Targeting TGF‐β1 Promoter G‐Quadruplex for Expediting Maturation of Tumor Dendritic Cells to Overcome Immune Evasion
Small Methods · 2026
DOI: 10.1002/smtd.202500650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2026. Verfasst von Chenglong Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Rare Earth Resource Utilization and Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy…. Hauptthemen laut MEDLINE: Dendritic Cells, Transforming Growth Factor beta1, G-Quadruplexes, Promoter Regions, Genetic. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
The maturation of dendritic cells (DCs) represents a pivotal determinant in tumor immunotherapy efficacy. In advanced tumors, the immune‐suppressive transforming growth factor‐beta 1 (TGF‐β1) is frequently overexpressed and plays a central role in immune suppression. Elevated TGF‐β1 levels significantly impair DCs maturation, leading to reduced expression of major histocompatibility complex (MHC) molecules and inflammatory cytokines, consequently diminishing DCs‐mediated T cell activation. Here, this work first validates the presence of a stable G‐quadruplex (G4) structure within the TGF‐β1 promoter region. To minimize the off‐target effects, this work establishes a system precisely targeting TGF‐β1 promoter G4. Through CRISPR‐mediated precise targeting of TGF‐β1 promoter G4 by G4 ligand biotin‐labeled pyridodicarboxamide (Bio‐PDC), this work demonstrates its functional role in downregulating TGF‐β1 expression. By combing ZIF‐8 as the carrier of Bio‐PDC, the downregulation of TGF‐β1 is enhanced in a dual pathway, which subsequently facilitated DCs maturation. These results highlight the key regulatory role of TGF‐β1 promoter G4 in DCs maturation and suggest its therapeutic potential as a synergistic target for enhancing immunotherapy efficacy by counteracting tumor immune evasion mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Rare Earth Resource Utilization and Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230029, P. R. China.
- State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, 130012, P. R. China.
ORCID-Profile: Chuanqi Zhao
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Ma, C., Sun, Y., Yuan, H., Ya, J., Wang, C., Zhao, C., & Qu, X. (2026). Precisely Targeting TGF‐β1 Promoter G‐Quadruplex for Expediting Maturation of Tumor Dendritic Cells to Overcome Immune Evasion. Small Methods. https://doi.org/10.1002/smtd.202500650
Vancouver
Ma C, Sun Y, Yuan H, Ya J, Wang C, Zhao C, et al. Precisely Targeting TGF‐β1 Promoter G‐Quadruplex for Expediting Maturation of Tumor Dendritic Cells to Overcome Immune Evasion. Small Methods. 2026. doi:10.1002/smtd.202500650
BibTeX
@article{Ma2026,
author = {Ma, Chenglong and Sun, Yue and Yuan, Heying and Ya, Junlin and Wang, Chunyu and Zhao, Chuanqi and Qu, Xiaogang},
title = {Precisely Targeting TGF‐β1 Promoter G‐Quadruplex for Expediting Maturation of Tumor Dendritic Cells to Overcome Immune Evasion},
journal = {Small Methods},
year = {2026},
doi = {10.1002/smtd.202500650}
}
EUVIMED